Impact GLP-1 Agonists Following Bariatric

Conditions: Morbid Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Obstructive Sleep Apnea of Adult Interventions: Drug: GLP-1 receptor agonist Sponsors: University of Missouri-Columbia; American Society for Metabolic and Bariatric Surgery Not yet recruiting

https://clinicaltrials.gov/study/NCT06132477

Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials